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1. Introduction 
Snake venoms are a complex mixture of compounds with a wide range of biological and 
pharmacological activities, which more than 90% of their dry weight is composed by 
proteins, comprising a variety of enzymes, such as proteases (metalo and serine), 
phospholipases A2, L-aminoacid oxidases, esterases, and others [1-5]. A great number of 
proteins were purified and characterized from snake venoms [1, 2]. Some of these proteins 
exhibit enzymatic activity, while many others are non-enzymatic proteins and peptides. 
Based on their structures, they can be grouped into a small number of super-families based 
on remarkable similarities in their primary, secondary and tertiary structures, however 
showing distinct pharmacologic effects [3]. 
One of the most important protein super-families present in snake venoms are the 
phospholipases A2 (PLA2, E.C. 3.1.1.4), a class of heat-stable and highly homologous 
enzymes, which catalyse the hydrolysis of the 2-acyl bond of cell membrane phospholipids 
releasing arachidonic acid and lysophospholipids (Figure 1). These proteins are found in a 
wide range of cells, tissues and biological fluids, such as macrophages, platelets, spleen, 
smooth muscle, placenta, synovial fluid, inflammatory exudate and animal venoms. There is 
a high medical and scientific interest in these enzymes due to their involvement in a variety 
of inflammatory diseases and accidents caused by venomous animals. Since the first PLA2 
activity was observed in Naja snake venom, PLA2s were characterized as the major 
component of snake venoms, being responsible for several pathophysiological effects caused 
by snake envenomation, such as neurotoxic, cardiotoxic, myotoxic, cytotoxic, hypotensive 
and anti-coagulant activities [1-10].  
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Phospholipases constitute a diverse subgroup of lipolytic enzymes that share the ability to 
hydrolyse one or more ester linkages in phospholipids, with phosphodiesterase as well as acyl 
hydrolase activity. The amphipathic nature of phospholipids creates obstacles for the enzymes, 
as the substrates are assembled into bilayers or micelles and are not present in significant 
amounts as a single soluble substrate [11]. According to Waite [12], all phospholipases target 
phospholipids as substrates, they vary in the site of action on the phospholipid molecule, their 
function and mode of action, and their regulation. Phospholipases function in various roles, 
ranging from the digestion of nutrients to the formation of bioactive molecules. This diversity 
of function suggests that phospholipases are relevant for life; the continuous remodelling of 
cell membranes requires the action of one or more phospholipases. The most common 
phospholipids in mammalian cells are phosphatidylcholine (PC), phosphatidylserine (PS), 
phosphatidylinositol (PI) and phosphatidylethanolamine (PE). The plasma membrane of most 
eukaryotic cells contains predominantly PC and sphingomyelin in the outer leaflet, and PI, PE 
and PS in the inner leaflet [11]. 
 
Figure 1. Phospholipase hydrolysis specificity sites in a 1,2-diacylglycerolphospholipid molecule 
(structure design from the ACD/l Lab. via Chem. Sketch – Freeware Version 1994 – 2009 software). 
Phospholipases are classified according to their site of action in the phospholipid molecule. 
Thus, a phospholipase A1 (PLA1) hydrolyzes the 1-acyl group of a phospholipid, the bond 
between the fatty acid and the glycerine residue at the 1-position of the phospholipid. A 
phospholipase A2 (PLA2) hydrolyzes the 2-acyl, or central acyl, group and phospholipases C 
(PLC) and D (PLD), which are also known as phosphodiesterases, cleave on different sides 
of the phosphodiester linkage (Figure 1). The hydrolysis of a phospholipid by a PLA1 or a 
PLA2 results in the production of a lysophospholipid. The phospholipase metabolites are 
involved in diverse cellular processes including signal transduction, host defense (including 
antibacterial effects), formation of platelet activating cofactor, membrane remodeling and 
general lipid metabolism [12-14]. 
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According to the latest classification [6], these proteins constitute a superfamily of different 
enzymes belonging to 15 groups and their subgroups including five distinct types of 
enzymes: the ones called secreted PLA2 (sPLA2), the cytosolic (cPLA2), the Ca2+ independent 
(iPLA2), the acetyl-hydrolases from platelet activating factors (PAF-AH) and the liposomal. 
The classification system groups these enzymes considering characteristics such as their 
origin, aminoacid sequence and catalytic mechanisms, among others. 
The sPLA2s have a Mr. varying from 13,000 to 18,000, usually containing from 5 to 8 
disulphide bond. They are enzymes that have a histidine in the active site and require the 
presence of the Ca2+ ion for the catalysis. Phospholipases A2 from the IA, IB, IIA, IIB, IIC, 
IID, IIE, IIF, III, V, IX, X, XIA, XIB, XII, XIII, XIV groups are representative of the sPLA2s. The 
cPLA2s are proteins with Mr between 61,000 to 114,000 that also use a serine in the catalytic 
site (groups IVA, IVB, IVC, IVD, IVE, IVF). The iPLA2s are enzymes which also use a serine 
for catalysis (groups VIA-1, VIA-2, VIB, VIC, VID, VIE, VIF). The PAF-AH are 
phospholipases A2 with serine in the catalytic site that hydrolyze the acetyl group from the 
sn-2 position of the platelet activating factors (PAF), whose representative groups are VIIA, 
VIIB, VIIIA, VIIB. The liposomal PLA2s are assembled in group XV and are enzymes with an 
optimum pH close to 4.5 that have preserved histidine and aspartate residues, suggesting 
the presence of the catalytic triad Ser/His/Asp and also a supposed sequence N-terminal 
sign and N-bond glycosylation sites [6]. 
With the discovery of a great variety of phospholipase A2 in the last decade and the present 
expansion of the research in the area, more PLA2s should be discovered yet. Phospholipase 
A2 found in snake venoms (svPLA2s) are classified into groups I and II. The phospholipase 
A2 from group I have two to three amino acids inserted in the 52-65 regions, called “elapid 
loop”, being isolated from the snake venoms of the Elapidae family (subfamily: Elapinae 
and Hydrophiinae). The ones from group II are characterized by the lack of the Cys11-Cys77 
bond which is substituted by a disulphide bond between the Cys51-Cys133, and besides that 
had five to seven amino acids extending the C-terminal regions, being bound in snake 
venoms of the Viperidae family (subfamily Viperinae and Crotalinae) [15,16]. 
The myotoxic PLA2s of the IIA class have been subdivided in two main groups: The Asp49, 
catalytically active; and the Lys49, catalytically inactive. The essential co-factor for the 
phospholipase A2 catalysis Ca2+. The phospholipase A2 Asp49 require calcium to stabilize 
the catalytic conformation, presenting a calcium bond site that is constituted by the β-
carboxylic group of Asp49 and the C=O carbonylic groups of the Tyr28, Gly30 and Gly32. 
The presence of two water molecules structurally preserved complete the coordination 
sphere of Ca2+ forming a pentagonal pyramid [9,15]. 
The catalytic mechanism of the PLA2-phospholipid involves the nucleophilic attack of a 
water molecule to the sn-2 bond of the phospholipid substrate (Figure 2). In the proposed 
model, the proton from position 3 of the imidazole ring of the His48 residue involved in a 
strong interaction with the carboxylate group of the Asp49 prevents the imidazole ring 
rotation to occur and keeps the nitrogen at position 1 of this ring, in an appropriate special 
position. A water molecule then promotes the nucleophilic attack to the carbon of the ester 
group of the substrate and, at this moment, the imidazole ring of the His48 receives a proton 
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from the water molecule, favoring the reaction. Subsequently to the acyl-ester bond 
hydrolysis at the sn-2 position of the phospholipid, this proton is donated by the imidazole 
ring to the oxygen, which then forms the alcohol group of the lysophospholipid to be 
released together with the fatty acid [15,17]. 
The Ca2+ ion, coordinated by the Asp49 residue, a water molecule and the oxygen atoms 
from the Gly30, Trp31 and Gly32 (not shown), are responsible for the stabilization of the 
reactive intermediary [15]. 
 
Figure 2. Schematic representation of the catalysis mechanism proposed for the PLA2s. Interaction of 
the residues from the catalytic site of sPLA2s and the calcium ion with the transition state of the catalytic 
reaction in which a water molecule polarized by the His48 and Asp99 residues binds to the carbonyl 
group of the substrate [18]. 
The substitution of the Asp49 residue by the Lys49 significantly alters the binding site of Ca2+ 
in the phospholipase A2, preventing its binding and resulting in low or inexistent catalytic 
activity. Thus, the Asp49 residue is of fundamental importance for the catalytic mechanism of 
the phospholipase A2. It is likely that this occurs due to its capability of binding and orienting 
the calcium ion, however, there is no relevant difference between Asp49 and Lys49 in relation 
to the structural conformation stability of these enzymes [9,15,19]. 
The absence of catalytic activity does not affect myotoxicity. Most snake PLA2s from the 
Bothrops genus already described are basic proteins, with isoelectric point between 7 to 10, 
showing the presence or absence of catalytic, myotoxic, edematogenic and anticoagulating 
activities [9,20]. 
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On the other hand, acid PLA2s present in Bothrops snake venoms were not studied as well 
as basic PLA2s, resulting in little knowledge regarding the action mechanism of these 
enzymes [21-25]. 
PLA2s catalytic activity represents a key role in envenomation pathophysiology, however, 
recent studies have shown that some effects are independent of PLA2s catalytic activity, 
such as myotoxicity [19,26]. The absence of a tight correlation between PLA2 catalytic and 
non-catalytic activities, together with the diversity of biological effects produced by these 
proteins increases the scientific interest in the understanding of the structural basis of PLA2 
mechanisms of action. 
Evidences suggest that these activities can be mediated by interactions between PLA2s and 
endogen acceptors on the target cell membrane [27-29]. 
2. PLA2 purification 
Snake venom components, obtained with high degree of purity, could be used for the 
understanding of the role of these components in the physiopathological processes resulted 
from poisoning, as well as biotechnological/nanotechnological applications. Hence, many 
purified PLA2s from snake venoms, as well as epitopes of these molecules, are being 
mapped in order to identify determinants responsible for the deleterious actions seen, as 
well as possible applications in biotechnological models. 
New advances in materials and equipments have contributed with protein purification 
processes, allowing the obtaining of samples with high degree of purity and quantity. These 
advances have allowed process optimization, providing reduction of steps, reagents use and 
thus avoiding the unnecessary exposure to agents that may, in some way, alter the sample’s 
functionality or physical-chemical stability. 
Thus, the selection of adequate techniques and chromatographic methods oriented by 
physical chemical properties and biological/functional characteristics, are of fundamental 
importance to obtain satisfactory results. The information pertinent to protein structure, 
such as the homology to others already purified, should be taken into consideration and 
could make the purification processes easier. 
Ion exchange chromatography was introduced in 1930 [30] and still one of the main 
techniques used for protein purification. It has been extensively used in single step 
processes as well as associated to other chromatographic techniques. Ion exchange 
chromatography allows the separation of proteins based on their charge due to amino acid 
composition that are ionized as a function of pH. 
Proteins with positive net charge, in a certain pH (bellow their isoelectric point), can be 
separated with the use of a cation exchange resin and on the other hand, proteins with 
negative net charge in a pH value above their isoelectric point, can be separated with an 
anion exchange resin. 
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Scientific publications have shown that the use of cation-exchange resins is a very efficient 
method to obtain PLA2s from bothropic venoms, particularly those with alkaline pH (Table 1). 
The versatility of this technique can be observed in the work done by Andriao-Escarso et al. 
[21] who compared the fractioning of many bothropic venoms. In this work, the venoms were 
fractioned in a column containing CM-Sepharose® (2 x 20 cm), equilibrated with ammonium 
bicarbonate 50 mM pH 8.0 and eluted with a saline gradient of 50 to 500 mM of the same 
reagent. Under these conditions, MjTX-I and MjTX-II from B. moojeni snake venom were co-
purified (isoforms of PLA2 with pIs of 8.1 and 8.2 values, respectively). The same occurs with 
B. jararacussu venom, where the BthTX-I and BthTX-II were purified. However, the most 
expressive result was observed with B. pirajai venom, from which 3 isoforms of myotoxins, 
called as PrTX-I (pI 8.50), PrTX-II (pI 9.03) and PrTX-III (pI 9.16) were purified. In the above 
cases, it is important to note that the protein elution occurs always following pIs increasing 
value. In our lab we used this technique routinely in order to isolate myotoxins from bothropic 
venoms, which can be observed in the chromatograms shown in Figure 3. 
 
Figure 3. Chromatographic profile using CM-sepharose® Column 1ml (Hitrap) equilibrated with Tris 
50 mM buffer (buffer A) and eluted with a linear gradient of Tris 50 mM/NaCl 1 M (buffer B) in pH 8.0. 
A. Chromatography of the crude venom from Bothrops brazili B. Chromatography of the crude venom 
from Bothrops moojeni C. Chromatography of the crude venom from Bothrops jararacussu. Absorbance 
read at 280 nm. ,2,3,4,5 and 6 marks indicate the fractions corresponding to the PLA2s of each venom. 
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Species PLA2 
PLA2 
Activity 
MW 
(kDa) 
pI 
Access 
Number 
(Uniprot) 
Purification strategy Ref. 
Agkistrodon bilineatus PLA2 Absence 14.0 10.2 Q9PSF9 Gel filtration chromatography on Sephadex G-75® and 
then submitted to íon-exchange on CM-Cellulose® 
column. 
[78] 
Agkistrodon contortrix 
contortrix 
PLA2 Presence 14.0   Ion-exchange chromatography on DEAE-Cellulose® 
column, followed by affinity chromatography with 
immobilized BSA and then submitted to gel filtration on 
Cellulofine GCL-2000® column. 
[79] 
Agkistrodon contortrix 
laticinctus 
MT1 Absence 14.0 9.0 49121 Anion-exchange chromatography on Waters DEAE-
5PW® column and then submitted to cation-exchange on 
Protein Pak SP-SPW® column. 
[80] 
Agkistrodon contortrix 
laticinctus 
ACL-I Presence 14.0   Gel filtration chromatography on Superdex-200® column 
and then submitted to ion-exchange on CM-Sepharose 
FF® column. 
[81] 
Atropoides nummifer Myotoxin IH Absence 16.0   Cation-exchange chromatography on CM-Sephadex C-
25® column. 
[82] 
Atropoides nummifer Myotoxin I Absence 16.0   Cation-exchange chromatography on CM-Sephadex C-
25® column. 
[83] 
Atropoides nummifer Myotoxin II Absence 13.7 8.7 P82950 Cation-exchange chromatography on CM-Sephadex C-
25® column. 
[84] 
Bothriechis (Bothrops) 
schlegelii 
Miotoxina II Presence 15.0 >9.5 P80963 Ion-exchange chromatography on CM-Sephadex® 
column. 
[85] 
Bothrocophias hyoprora PhTX-I Presence 14.2   Reverse Phase chromatography on Bondapack® C-18 
column. 
[86] 
Bothropoides insularis SIII-SPVI Presence 15.0   Gel filtration chromatography on Sephadex G-150® 
column and then submitted to SP-Sephadex C25® 
column. 
[87] 
Bothropoides insularis BinTX-I 
BinTX-II 
Presence 
Presence 
13.9 
13.7 
5.0 
4.4 
Q8QG87 
P84397 
Reverse Phase chromatography on Vydac® C18 column. [88] 
Bothropoides insularis Bi PLA2 Presence 13.9 8.6  Gel filtration chromatography on Superdex 75® column 
and then submitted to cation-exchange on Protein pack 
SP-5PW® column and Reverse Phase chromatography on 
µ-Bondapack® C18 column. 
[89] 
Bothropoides jararaca BjPLA2 Presence 14.0  P81243 Ion-exchange chromatography on DEAE Sephacel® 
column and then submitted to Reverse Phase 
chromatography on Ultrapore RPRC-C3® column. 
[90] 
Bothropoides jararaca PLA2 Presence 14.2 4.5 Q9PRZ0 Gel filtration on Sephacryl S-200® column and then 
submitted to reverse phase on Pep-RPC HR 5/5® column. 
[91] 
Bothropoides pauloensis BpPLA2 Presence 15.8 4.3 D0UGJ0 Cation-exchange chromatography on CM-Sepharose® 
column followed by Phenyl-Sepharose CL-4B® column 
and then submitted to reverse phase chromatography on 
C8 column. 
[23] 
Bothropoides pauloensis BnSP-7 Absence 13.7 8.9 Q9IAT9 Cation-exchange chromatography on CM-Sepharose® 
column or heparin agarose® column. 
[26] 
Bothrops alternatus BA SpII RP4 Presence 14.1 4.8 P86456 Gel filtration chromatography Sephadex G-75® column 
followed by reverse phase chromatography on C18 column. 
[92] 
Bothrops alternatus PLA2 Presence 15.0 5.0  Gel filtration chromatography on Sephadex G-50® 
column followed by ion-exchange on SP Sephadex C-50® 
column and then submitted to gel filtration 
chromatography on Sephadex G-75® column. 
[93] 
Bothrops alternatus BaTX Absence 13.8 8.6 P86453 Gel filtration chromatography on Superdex 75® column 
followed by reverse phase chromatography on µ-
Bondapack® C18 column. 
[94] 
Bothrops asper MTX-I 
MTX-II 
MTX-III 
MTX-IV 
Basp-I-PLA2 
Presence 
Absence 
Presence 
Absence 
Presence 
14.1 
14.2 
14.2 
Nd 
14.2 
8.1- 8.3 
8.1- 8.3 
8.1- 8.3 
8.1- 8.3 
4.6 
 Ion-exchange chromatography on CM-Sepharose® 
column followed by hydrophobic interaction 
chromatography on Phenyl-Sepharose® column. 
[95] 
Bothrops asper Myotoxin I Presence 10.7 nd  Ion-exchange chromatography on CM-Sephadex C-25® 
column followed by gel filtration chromatography on 
Sephadex G-75® column. 
[7] 
Bothrops asper Myotoxin II Absence 13.3 nd P24605 Ion-exchange chromatography on CM-Sephadex C-25® 
column. 
[96] 
Bothrops asper Myotoxin III Presence 13.9 >9.5 P20472 Ion-exchange chromatography on CM-Sephadex C-25® 
column. 
[97] 
Bothrops asper Myotoxic 
PLA2 
Presence 14.1 nd  Gel filtration chromatography on Sephadex G-75® 
followed by ion-exchange chromatography on CM-
cellulose® column. 
 
[98] 
Bothrops asper BaspPLA 2-II Presence 14.2 4.9 P86389 Ion-exchange on CM-Sephadex C-25® followed by 
chromatography on DEAE Sepharose® column, active 
fractions subjected to reverse phase chromatography on 
C8 column and finally chromatography with CM- 
[22] 
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Bothrops atrox BaPLA2I 
BaPLA2 III 
Presence 
Presence 
15.0 
15.0 
9.1 
6.9 
 Gel filtration chromatography on Sephacryl S-100 HR® 
column followed by reverse phase on C4 column. 
[99] 
Bothrops atrox Basic 
Myotoxin 
Presence 13.5   Ion-exchange chromatography on CM-Sephadex C-25® 
column and then re-chromatographed on the same column 
and same conditions. 
[32] 
Bothrops atrox Myotoxin I Absence 13.8 8.9 Q6JK69 Ion-exchange chromatography on Carboximetil-Sephadex 
C-25® followed by reverse phase chromatography on C8 
column. 
[100] 
Bothrops brazili MTX-I 
MTX-II 
Presence 
Absence 
14.0 
14.0 
  Ion-exchange chromatography on CM-Sepharose® 
column. 
[101] 
Bothrops brazili BbTX-II 
BbTX-III 
Absence 
Presence 
13.9 
13.6 
8.7 
8.4 
 Reverse phase chromatography on C18 column. [102] 
Bothrops erythromelas BE-I-PLA2 Presence 13.6   Gel filtration chromatography on Superdex 75® followed 
by chromatography on monoQ® column, fractions being 
subjected to reverse phase chromatography on C4 column 
afterwards. 
[103] 
Bothrops jararacussu BthTX-I 
BthTX-II 
Absence 
Presence 
13.0 
13.0 
8.2 
 
Q90249 
P45881 
Gel filtration chromatography on Sephadex G-75®, 
followed by cation-exchange chromatography on SP-
Sephadex C-25® column. 
[34] 
Bothrops jararacussu BJ IV Presence 15.0  P0CAR8 Ion-exchange chromatography on Protein Pack SP 5PW® 
column followed by reverse phase chromatography on µ-
Bondapack® C18 column. 
[104] 
Bothrops jararacussu BthA-I-PLA2 Presence 13.7 4.5 Q8AXY1 Ion-exchange chromatography on CM-Sepharose® 
column, followed by reverse phase chromatography on 
C18 column. 
[58] 
Bothrops jararacussu SIIISPIIA 
SIIISPIIB 
SIIISPIIIA 
SIIISPIIIB 
Presence 
Presence 
Presence 
Presence 
15.0 
15.0 
15.0 
15.0 
5.3 
5.3 
5.3 
5.3 
 Gel filtration chromatography on Sephadex G-75® 
column, followed by ion-exchange chromatography on 
SP-Sephadex C-25® column, and finally HPLC on C18 
column. 
[105] 
Bothrops lanceolatus PLA2-1 
PLA2-2 
PLA2-3 
Presence 
Presence 
Presence 
15.0 
13.0 
18.0 
5.3 
5.3 
5.3 
 Reverse phase chromatography on Lichrosfera RP100® 
C18 column. 
[106] 
Bothrops leucurus BLK-PLA2 
BLD-PLA2 
Absence 
Presence 
14.0 
14.0 
 P86974 
P86975 
Gel filtration chromatography on Sephacryl S-200®, 
followed by ion-exchange on Q-Sepharose and then 
submitted to reverse phase chromatography on HPLC 
Vydac® C4. 
[38] 
Bothrops leucurus Bl-PLA2 Presence 15.0 5.4 P0DJ62 Ion-exchange chromatography on CM- Sepharose® 
column, followed by hydrophobic interaction 
chromatography on Phenyl-Sepharose® column. 
[43] 
Bothrops marajoensis BmjeTX-I 
BmjeTX-II 
Presence 
Presence 
13.8 
13.8 
 P86803 
P86804 
Ion-exchange chromatography on Protein Pack SP 5PW®, 
followed by reverse phase chromatography on µ-
Bondapack® C18 column. 
[107] 
Bothrops marajoensis BmarPLA2 Absence 14.0 nd P0DI92 Ion-exchange chromatography on Protein Pack SP 5PW®, 
followed by reverse phase chromatography. 
[108] 
Bothrops marajoensis Bmaj-9 Presence 13.7 8.5 B3A0N3 Reverse phase chromatography on µ-Bondapack® C18 
column. 
[109] 
Bothrops moojeni BthA-I Presence 13.6 5.2 G3DT18 Ion-exchange on CM-Sepharose® column, followed by 
hydrophobic interaction chromatography on Phenyl-
Sepharose® column. 
[24] 
Bothrops moojeni MjTX-III 
MjTX-IV 
Absence 
Absence 
14.6 
14.6 
  Gel filtration chromatography on Superdex -75XK® 
column, followed by reverse phase chromatography on 
C18 column. 
[110] 
Bothrops moojeni MjTX-I ou 
Miotoxina-I 
Absence 13.4 8.2 P82114 Ion-exchange chromatography on CM-Sepharose® 
column. 
[26] 
Bothrops moojeni MjTX-II Absence 14.0 8.2 Q9I834 Ion-exchange chromatography on CM-Sepharose® 
column. 
[111] 
Bothrops moojeni BmooTX-I Presence 15.0 4.2  Ion-exchange on DEAE-Sepharose®, gel filtration on 
Sephadex G-75® column and hydrophobic interaction 
chromatography on Phenyl-Sepharose®. 
[42] 
Bothrops moojeni BmTX-I Presence 14.2 7.8 P0C8M1 Reverse phase chromatography on µ-Bondapack® C18 
column. 
[112] 
Bothrops moojeni BmooMtx Absence 16.5   Ion-exchange chromatography on DEAE-Sephacel® 
column and then submitted to gel filtration on Sephadex 
G-75® column. 
[113] 
Bothrops pirajai Piratoxin-I Absence 13.8 8.3 P58399 Gel filtration chromatography on Sephadex G-75® 
column, followed by ion-exchange chromatography on 
Sephadex C25® column. 
[114] 
Bothrops pirajai Piratoxin-III 
ou MPIII 4R 
Presence 13.8  P58464 Ion-exchange chromatography on semi-preparative u-
Bondapack® column, followed by ion-exchange 
chromatography on Protein Pack SP 5PW® column. 
[115] 
Bothrops pirajai Bpir-I PLA2 Presence 14.5  C9DPL5 Ion-exchange chromatography on CM- Sepharose FF® 
column, followed by reverse phase chromatography on 
C18 column. 
[25] 
Bothrops pirajai Piratoxin -II Absence 13.7 9.0 P82287 Gel filtration chromatography on Sephadex G-75® 
column and ion-exchange chromatography on Sephadex 
C25® column. 
[116] 
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Table 1. PLA2s isolated from American snake venoms and respective chromatographic methods used. 
Some authors have proposed changes to the methodology described above. Spencer et al. 
[31] described the purification of BthTX-I with the use of Resourse S® (methyl-sulphonate 
Cerrophidion goodmani Myotoxin I 
Myotoxin II 
Presence 
Absence 
14.3 
13.4 
8.2 
8.9 
 Ion-exchange chromatography on CM-Sephadex® 
column. 
[117] 
Cerrophidion goodmani GodMT-II Absence 13.7   Ion-exchange chromatography on CM-Sephadex® 
column. 
[118] 
Cerrophidion goodmani Pgo K49 Absence 13.8   Gel filtration chromatography on Sephadex G-75 HR® 
column, followed by reverse phase chromatography on 
Vydac® C8 column. 
[119] 
Crotalus atrox PLA2–1 
PLA2–2 
Absence 
Presence 
15.3 
15.5 
4.6 
8.6 
 Gel filtration chromatography on DEAE-cellulose® 
column. 
[119] 
Crotalus atrox Cax-K49 Absence 13.8  Q81VZ7 Gel filtration chromatography on DEAE-cellulose® 
column. 
[119] 
Crotalus durissus 
cascavella 
PLA2 Presence 15.0   Gel filtration chromatography (pharmacia), followed by 
reverse phase on µ-Bondapak® C-18 column. 
[120] 
Crotalus durissus 
collilineatus 
F6a Presence 14.9 5.8 P0CAS2 Reverse phase chromatography on µ-Bondapack® C18 
column. 
[121] 
Crotalus durissus 
cumanensis 
Cdc-9 
Cdc-10 
Presence 
Presence 
14.1 
14.2 
8.25 
8.4 
P86805 
P86806 
Reverse phase chromatography on µ-Bondapack® C18 
column. 
[122] 
Crotalus durissus 
cumanensis 
Cdcum6 Presence 14.3 Nd P0CAS1 Gel filtration chromatography followed by reverse phase 
chromatography. 
[123] 
Crotalus durissus 
ruruima 
PLA2A Presence 14.2  P86169 Gel filtration chromatography followed by reverse phase 
chromatography. 
[124] 
Crotalus durissus 
ruruima 
Cdr-12 
Cdr-13 
Presence 
Presence 
14.3 
14.2 
8.1 
8.1 
P0CAS3 
P0CAS4 
Reverse phase chromatography on µ-Bondapack® C18 
column. 
[121] 
Crotalus durissus 
terrificus 
CdtF16 Presence 14.8  P0CAS6 Gel filtration chromatography on Superdex 75® column, 
followed by reverse phase chromatography on µ-
Bondapack® C18. 
[125] 
Crotalus durissus 
terrificus 
Crotoxin B Presence 14.5 5.1  Gel filtration chromatography on Sephadex G75® column, 
followed by chromatography on Mono-Q® and finally 
ion-exchange chromatography followed by DEAE-
cellulose® column. 
[126] 
Crotalus durissus 
terrificus 
CdtF17 Presence 14.6 8.15 P0CAS7 Reverse phase chromatography on µ-Bondapack® C-18 
column. 
[127] 
Crotalus durissus 
terrificus 
CdtF15 Presence 14.5 8.8 P0CAS5 Gel filtration chromatography on Superdex 75® column 
followed by reverse phase chromatography on µ-
Bondapack® C-18 column. 
[128] 
Crotalus scutulatus 
scutulatus 
MTX-a 
MTX-b 
 14.5 
14.4 
9.2 
7.4 
P18998 
P62023 
 Reverse phase on Vydac® C8 column. [129] 
Lachesis muta LmTX-I 
LmTX-II 
Presence 
Presence 
14.2 
14.1 
8.7 
8.6 
P0C942 
P0C943 
Gel filtration chromatography on Superdex 75® column, 
followed by reverse phase chromatography on µ-
Bondapack® C-18 column and finally reverse phase 
chromatography on C8 column. 
[130] 
Lachesis muta LM-PLA2-I 
LM-PLA2-II 
Presence 
Presence 
17.0 
18.0 
4.7 
5.4 
P0C932 
P0C933 
Gel filtration chromatography on Sephacryl S-200® 
column, followed by reverse phase chromatography on C2 
column and finally reverse phase chromatography on C18 
column. 
[131] 
Lachesis stenophys LSPA-1 Presence 13.8 nd P84651 Gel filtration chromatography on Sephacryl S-200® 
column followed by ion-exchange chromatography using 
MonoQ HR 5/5® column and finally reverse 
chromatography on Sephasil® C-18 column. 
[132] 
Porthidium nasutum PnPLA2 Presence 15.8 4.6  Reverse phase chromatography on C18 column. [133] 
Micrurus tener tener MitTx-beta Presence 16.7  G9I930 Reverse phase chromatography on C18 Vydac® column 
followed by reverse phase on Vydac® C18 column. 
[134] 
Micrurus tener 
microgalbineus 
PLA2-1 Presence   P25072 Gel filtration chromatography on Sephadex G-50® 
followed by ion-exchange chromatography on CM-
cellulose column. 
[135] 
Micrurus pyrrhocryptus PLA2 A1 
PLA2 B1 
PLA2 D5 
PLA2 D6 
Presence 
Presence 
Presence 
Presence 
  P0CAS8 
P0CAS9 
P0CAT0 
P0CAT1 
Gel filtration chromatography on Superdex G 75 HR® 
followed by reverse phase chromatography on Vydac® 
C18 column. 
[136] 
Micrurus nigrocinctus Nigroxin A 
Nigroxin B 
Presence 
Presence 
  P81166 
P81167 
Ion-exchange chromatography on Mono Q FF® column 
followed by reverse phase chromatography on Vydac® C4 
column. 
[137] 
Micrurus nigrocinctus PLA2-1 
PLA2-2 
PLA2-3 
Presence 
Presence 
Presence 
  P21790 
P21791 
P21792 
Gel filtration chromatography on Sephadex G-75® 
column followed by ion-exchange chromatography on 
CM-cellulose® column. 
 
[138] 
Micrurus dumerilli 
carinicauda 
MiDCA1 Presence 15.5 8.0  Reverse phase chromatography on Sephasil Peptide® C18 
column followed by reverse phase chromatography on µ-
Bondapak® C18 column. 
[139] 
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functional group), equilibrated in pH 7.8 (phosphate buffer 25 mM). Sample elution was 
done in increasing ionic strength conditions (NaCl 0 to 2 M), under 2.5 ml/min flow. In this 
model, the BthTX-I was eluted in NaCl 0.42M with a high degree of purity. However, the 
chromatographic profile in the conditions tested differs significantly from the observed in 
other works that describe the fractioning of this venom. This difference is due to the resin 
composition. This is corroborated with data obtained in experiments performed in our lab, 
where the effect of pH in the separation of myotoxin isoforms from B. jararacussu venom 
was used, as shown in Figures 4. SDS-PAGE showed that fractions corresponding to 
myotoxins showed protein bands with apparent molecular mass compatible with PLA2s 
class II (Figure 5). 
 
 
 
Figure 4. Chromatographic profile of the B.jararacussu venom in CM-sepharose® column 1 ml (Hitrap) 
equilibrated with Tris 50 mM buffer (buffer A) and eluted with a linear gradient of Tris 50 mM/NaCl 
1M (buffer B) in different pH conditions. A. pH 5.0 B. pH 6.0 C. pH 7.0 D. pH 8.0. Absorbance was read 
at 280 nm. Fractions numbered (1 to 8) indicate the fractions selected for SDS-PAGE analysis in order to 
confirm the presence of PLA2s (BthTx I e BthTx II). 
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Figure 5. SDS Page analysis. Lines 1 and 2 (pH 5.0); 3 and 4 (pH 6.0); 5 and 6 (pH 7.0); 7 and 8 (pH 8.0). 
BthTx I was obtained in high degree of purity with pHs 5.0, 6.0, and 8.0. BthTx II was obtained with pH 
7.0. 
Resolution differences were also observed by other authors. As performed by Lomonte et al. 
[26], the isolation of two basic myotoxins, MjTX-I e MjTX-II, from the B. moojeni venom was 
obtained using CM-Sephadex C-25 equilibrated with Tris-HCl 50 mM pH 7.0 and eluted in 
saline gradient up to 0.75 M of Tris-HCl. Also, Soares et al. [33] described the isolation of 
MjTX-II with high purity using the combination of CM-Sepharose resin and ammonium 
bicarbonate buffer. According to the authors, the increase of pH to 8.0 has favored the 
elution of several fractions, allowing MjTX-II to be eluted separately with ionic strength 
equal to 0.35 M of ammonium bicarbonate. Moreover, the use of CM-Sepharose® seems to 
have also contributed a lot in the increasing of resolution for this chromatographic 
separation. 
The combination of chromatographic techniques has also been used to purify these toxins. 
The association of the Ion-exchange chromatography and molecular exclusion has been one 
of the most recurrent in isolation and purification of phospholipases from bothropic 
venoms. Gel filtration chromatography is a technique based in particle size to obtain the 
separation. In this type of separation there is no physical or chemical interaction between 
the molecules of the analyte and the stationary phase, being currently used for separation of 
molecules with high molecular mass. The sample is introduced in a column, filled with a 
matrix constituted by small sized silica particles (5 to 10 µm) or a polymer containing a 
uniform net pores of which solvent and solute molecules diffuse. The retention time in the 
column depends on the effective size of the analyte molecules, the higher sized being the 
first ones to be eluted. Different from the higher molecules, the smaller penetrate the pores 
being retained and eluted later. Between the higher and lower molecules, there are the 
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intermediary sized molecules, whose penetration capacity in the pores depends on their 
diameter. In addition to that, this technique has also some very important characteristics, 
such as operational simplicity, physical chemical stability, inertia (absence of reactivity and 
adsorptive properties) and versatility, since it allows the separation of small molecules with 
mass under 100 Da as well as extremely big molecules with various kDa. 
The work performed by Homsi-Brandeburgo et al. [34] is a example of combination of 
different chromatographic techniques for the isolation of myotoxins with PLA2 structure. It 
describes for the first time the BthTX-I purification using the combination of molecular 
exclusion chromatography in Sephadex G-75® resin followed by Ionic exchange 
chromatography in SP-Sephadex C-25®. In the first step, four fractions were obtained, called 
SI, SII, SIII and SIV. The Functional analysis of these fractions showed that the proteolytic 
activity over casein and fibrinogen was detected on fraction SI, while the phospholipase 
activity was concentrated in fraction SIII. The apparent molecular mass profile of this fraction 
showed that it was composed by proteins between 12,900 and 28,800 Da, compatible with 
the mass profile of the class II PLA2s. 
On the second step, SIII fraction was submitted to ionic exchange chromatography and five 
fractions were obtained, identified as SIIISPI to SIIISPIV. The pIs and apparent molecular mass 
evaluation showed the following profile: SIIIPI (pI 4.2 and 22.400 Da), SIIIPII (pI 4.8 and 15.500 
Da), SIIIPIII (pI 6.9 and dimeric structure, each monomer with a molecular mass of 13.900 Da), 
SIIIPIV (pI 7.7 and 13.200 Da) e SIIIPV called BthTX-I that presented pI 8,2 and 12.880 Da. 
Pereira et al. [35] obtained the complete sequence of BthTX-II, a myotoxin homologous to 
the BthTX-I, which corresponds to the SIIISPIV fraction described by Homsi-Brandeburgo et 
al. [34]. 
Another chromatographic technique regularly used in PLA2s purification procedures is 
the Reverse-phase associated with High performance liquid chromatography (RP- HPLC). 
This technique is characterized by its high resolution capacity and is normally used in a 
more refined step of the purification process, being very useful in separating isoforms. 
The retention principle of reverse-phase chromatography is based in hydrophobicity and 
is mainly due to the interactions between hydrophobic domains of the proteins and the 
stationary phase. This technique has many advantages, such as: use of less toxic mobile 
phases together with lower costs, such as methanol and water; stable stationary phases; 
fast column equilibrium after mobile phase change; easy to use gradient elution; faster 
analysis and good reproducibility. 
Rodrigues et al. [36] described the isolation of two PLA2s isoforms from the B. neuwiedi 
pauloensis venom using the combination of ion (cation) exchange chromatography and 
molecular exclusion setting up a preparative phase. Subsequently, a reverse-phase 
chromatography was used for the analytical phase of the procedure. Initially, the venom 
was fractioned in a column containing CM-Sepharose® equilibrated with ammonium 
acetate solution 0.05 M, pH 5.5 and eluted in linear gradient up to 1 M of the same buffer, 
resulting in six fractions. The pH, more acid than the ones used in the work previously 
mentioned, has increased the surface residual charge, intensifying the interaction force 
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between the protein and the resin, thus altering the elution profile when compared to the 
performed by Rodrigues et al. [37]. Proceeding with purification, the sample with 
phospholipase activity (S-5) was submitted to a new fractioning in a Sephadex G-50® 
column yielding 3 fractions, of which the denominated S-5-SG-2 showed catalytic activity. It 
was then submitted to RP- HPLC in C18 column to obtain toxins with high purity degree. 
Also, with the use of a multiple step procedure [38] successfully isolated two isoforms of 
PLA2s from B. leucurus venom. After a first molecular exclusion chromatography using 
Sephacryl S-200®, 7 fractions were obtained, from which the named “P6” showed to be 
composed by proteins with apparent molecular mass bellow 30 kDa, and a major fraction of 
approximately 14 kDa concentrated the phospholipase activity. This fraction was re-
chromatographed in a Q-Sepharose® resin (ion exchange) and equilibrated with Tris-HCl 20 
mM pH 8.0, yielding 6 fractions. The fraction corresponding to the negatively charged 
fraction was eluted without significant interaction with the resin, hence with a positive 
residual charge (basic pI) was selected, showing to be a homogeneous fraction of 14 kDa and 
presenting phospholipase activity. This fraction was submitted to a RP- HPLC in C4 
column, yielding as result two major fractions with close hydrophobicity (eluted with 33% 
and 36% acetonitrile) and apparent molecular mass of 14 kDa. 
Myotoxins with PLA2s structure from bothropic venoms that have acid pI have being more 
difficult to isolate. Different from cation exchange resins (CM Sepharose®, Resource S® and 
CM Sephadex®), anion exchange resins have not been so efficient in the separation of 
components from bothropic venoms, which requires, complementary steps to obtain these 
toxins with a satisfactory purity degree, as shown in Table 1. 
Daniele et al. [32] described the fractioning of the B. neuwiedii venom using a combination of 
double molecular exclusion chromatography followed by anion exchange chromatography. 
The first step of the molecular exclusion chromatography was done using Sephadex G-50® 
where a single fraction with PLA2s activity was eluted. This fraction was re-
chromatographed in Sephacryl S-200® resin, yielding 2 active fractions. The first fraction 
was re-chromatographed in Mono Q® column (functional group quaternary ammonium) 
yielding a PLA2s named P-3. From the second fraction, submitted to the same 
chromatographic procedure, two other PLA2s isoforms were isolated, named P-1 and P-2. 
Although showing different behavior over the molecular exclusion resin, the three isoforms 
showed very close apparent molecular mass (15 kDa) when assayed by SDS-PAGE. This 
difference could be resulted from differential interactions of aromatic residues located on 
the protein surface with the stationary phase [40, 41] and can be also verified in other acid 
PLA2s, like the one obtained from B. jararacussu venom by Homsi-Brandeburgo et al. [34].  
Other procedures used hydrophobic interaction chromatography to isolate these PLA2s. This is 
a method that separates the proteins by means of their hydrophobicity: the hydrophobic 
domains of the proteins bind to the hydrophobic functional groups (phenyl and aryl) of the 
stationary phase. Proteins should be submitted to the presence of a high saline concentration, 
which stabilize then and increases water entropy, thus amplifying hydrophobic interactions. In 
the presence of high salt concentrations, the matrix functional groups interact and retain the 
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proteins that have surface hydrophobic domains. Hence, elution and protein separations can 
be controlled altering the salt or reducing its concentration. 
Santos-Filho et al. [42], working with B. moojeni venom, applied three sequential steps to 
obtain BmooTX-I, a PLA2 with apparent molecular mass of 15 kDa and pl 4.2. In this work, 
the crude venom was chromatographed in DEAE-Sepharose® (Dietylaminoetyl) resin, 
equilibrated with ammonium bicarbonate 50mM, pH 7.8 and brought to a saline gradient of 
0.3M of the same salt. A fraction named E3 showed phospholipase activity, being then 
submitted to molecular exclusion chromatography in Sephadex G-75® resin. Three fractions 
were obtained, from which one named S2G3 was submitted to hydrophobic interaction 
chromatography in Phenyl-Sepharose® resin, the BmooTX-I being eluted in the end of the 
process. 
In a work published in 2011, Nunes et al. [43] described the isolation of an acid phospholipase 
named BL-PLA2, obtained from Bothrops leucurus through two sequential chromatographic 
steps. On the first step, the acid proteins were separated from the others with the use of a 
cation exchange column (CM-Sepharose®) equilibrated with ammonium bicarbonate, pH 7.8. 
The acid fraction (eluted without interaction with the resin) was lyophilized and applied to a 
Phenyl-Sepharose CL-4B® column (1 x 10 cm), previously equilibrated with a Tris-HCl 10mM 
buffer, NaCl 4M, pH 8.5. The elution occurred under decreasing NaCl gradient in a buffered 
environment (Tris-HCl 10 mM, pH 8.5), concluding the process in an electrolyte free 
environment. An enzymatically active fraction (BL-PLA2), (with pI 5.4 and apparent molecular 
mass of approximately 15 kDa) was obtained at the end of the process. 
The bioaffinity chromatography differs from others chromatographic methods because it is 
based in biological or functional interactions between the protein and the ligand. The nature 
of these interactions varies, being the most used those which are based on the interactions 
between: enzymes and substrate analogous and inhibitors; antigens and antibodies; lectins 
and glycoconjugates; metals and proteins fused with histamine tails. The high selectivity, 
the easiness of performance together with the diversity of ligands that can be immobilized 
in a chromatographic matrix make this method a useful tool for the purification of 
phospholipases. Based on the neutralization of myotoxic effects of the venom from B. 
jararacussu by heparin [44-46], the use of a column containing Agarose-heparin® could be 
used for the purification of myotoxins. They also ratify the interactions between heparin and 
myotoxin through the reduction of many biological effects, such as: edema induction, 
myotoxicity (in vivo) and cytotoxicity over mice myoblasts culture (L.6 – ATCC CRL 14581) 
and endothelial cells. 
Following this strategy, Soares et al. [26] described the purification of BnSP-7, a myotoxin 
Lys-49 from B. neuwiedi pauloensis, with the use of chromatographic process based in this 
heparin functionality, which corroborates previous results obtained by Lomonte et al. [46], 
that showed the efficient inhibitory activity of heparin against myotoxicity and edema 
induced by myotoxin II, a lysine 49 phospholipase A2 from Bothrops asper. Also in this study, 
it was possible to infer the participation of the C-terminal region of the protein in the 
damaging effects on the cytoplasmic membrane.   
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Snake venom components share many similar antigenic epitopes that can induce to a 
crossed recognition by antibodies produces against a determined toxin. In this context, 
Stabeli et al. [47] showed that antibodies that recognize a peptide (Ile1-Hse11) from Bm-
LAAO present crossed immunoreactivity with components not related to the LAAOs group 
present in venoms from Bothrops, Crotalus, Micrurus e Lachesis snake venoms. Also, Beghini 
et al. [48] showed that the serum produced against crotoxin and phospholipase A2 from 
Crotalus durissus cascavella was able to neutralize the neurotoxic activity produced by B. 
jararacussu venom and BthTX-I. 
Based on this information, pertinent to the crossed immunoreactivity existent between 
venom components, Gomes et al. [49] described the co-purification of a lectin (BJcuL) and a 
phospholipase A2 (BthTX-1) using a immunoaffinity resin containing antibodies produced 
against the crotoxin. 20 mg of crotoxin was solubilized in coupling buffer (sodium 
bicarbonate 100 mM, NaCl mM, pH 8.3) and incubated overnight at 4 °C with 1 g of 
Sepharose® activated by cyanogen bromide (CNBr). After washing with the same buffer, 
the resin was blocked with Tris-HCl 100 mM buffer. This resin was packed and thoroughly 
washed with saline phosphate buffer (PBS) pH 7.4. Crotalic counter-venom hiperimune 
horse plasma (20 mg) was applied over the resin at a flow of 10 mL/hr and re-circulated 
overnight through the column. Then, it was washed until the absorbance went back to basal 
levels, showing that the material was retained (IgG anti-Ctx), then eluted with glycin-HCl 
100 mM pH 2.8. The IgG anti-Ctx was then immobilized in CNBr activated Sepharose® resin 
through a procedure analogous to the above cited, generating a new resin called Sepharose-
Bound Anti-CtxIgG. 20 mg of the crude venom from B. jararacussu was applied over this 
resin, yielding two fractions: the first, composed by proteins that were not recognized by the 
immobilized antibodies and a second fraction composed by components of venom from B. 
jararacussu that reacted crosswise with the Anti-Ctx antibodies, called Bj-F. A posterior 
analysis of this fraction, done by mass spectrometry, amino-terminal sequencing by Edman 
degradation and search by homology in the NCBI protein data bank, showed that it was 
composed by lectin and BthTX-I. 
Different authors used substrate analogous or reversible inhibitors coupled to the 
chromatographic resin. Rock and Snyder [50] were the first ones to use phospholipid 
analogous to build a bioaffinity matrix [Rac-1-(9-carboxy)-nonil-2-exadecilglycero-3-
phosphocoline]. In addition to them, Dijkman [51] described the synthesis of an analogous 
of acylamino phospholipid[(R)-1-deoxy-1-thio-(ω-carboxy-undecyl)-2-deoxy- (n-
decanoylamino)-3-glycerophosphocholine] which was coupled to a Sepharose 6B® resin 
containing a spacer arm. With the use of this resin it was possible to purify phospholipases 
from horse pancreas, and venoms from Naja melanonleuca and Crotallus adamanteus. 
3. Characterization 
Venomic can be defined as an analysis in large scale of the components present in the 
venom of a certain species. In this context, the proteomic approach has allowed a better 
understanding of the venom components, through the application of many instruments that 
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enables the analysis of their expression, structure, pos-traductional modifications and 
classification by homology or function. An approach developed by Calvete [52] for the 
analysis of snake venomic consists in an initial fractioning step of the crude venom using RP 
- HPLC, followed by characterization of each fraction by a combination of amino-terminal 
sequencing, SDS-PAGE, IEF or 2DE and mass spectrometry to determine molecular mass 
and cysteine content. Additionally, the modern venomic analysis use techniques such as 
Peptide Mass Fingerprint and the search for sequence similarity in data banks.  
SDS-PAGE is a method related to the migration of charged particles in a medium under the 
influence of a continuous electric field [53]. From the electrophoretic point of view, the most 
important properties of the proteins are molar mass, charge and conformation. Mono 
dimensional polyacrylamide gel electrophoresis permit the analysis of the protein in its 
native or denatured form. In the first case, there are no alterations in conformation, 
biological activity and between protein subunits. This system is called non-dissociating or 
native, which proteins are separated based on their charge, using the isoelectric focusing 
method (IEF), or else, in vertical gel without SDS. During the IEF, a pH gradient is formed 
and the charged species move through the gel until they reach a specific pH. In this pH, the 
proteins have no effective charge (known as protein pI). The IEF shows high resolution, 
being able to separate macromolecules with pI differences of just 0.001 pH units [54, 55]. In 
dissociating or denaturing systems, the proteins are solubilized in buffer containing the 
reagent used to promote protein denaturation. SDS-PAGE, originally described by Laemmli 
[56], is an electrophoresis technique in polyacrylamide gel (PAGE) that used SDS as a 
denaturing agent, with interacts with the proteins giving them negative charges, allowing 
them to migrate, through a polyacrylamide gel towards a positive electrode a be separated 
by the differences related to their mass 
Teixeira et al [25] described the purification of an acid phospholipase from B. pirajai 
(BpirPLA2I). As a biochemical characterization step, polyacrylamide gel electrophoresis in 
denaturing conditions (SDS-PAGE) was done. Using this approach, carried out in reducing 
and non-reducing conditions, the author could infer that the purified protein had the form 
of a monomer with apparent molecular mass of 14 kDa, both in reducing conditions as well 
as in non-reducing conditions the proteins presented the same mass, being confirmed 
afterwards by mass spectrometry. 
Moreover, Torres [57] fractionated B. marajoensis venom using a cationic ion exchange 
column followed by an analytical phase in RP- HPLC, obtaining a phospholipase BmarPLA2 
that was submitted to SDS-PAGE in reducing conditions showing apparent molecular mass 
of 14 kDa. However, in non-reducing conditions, the author observed the appearance of a 
single band at 28 kDa, concluding that BmarPLA2 was a dimeric structured protein joined 
by disulphide bridges. Thus, the above-cited examples demonstrate the importance of this 
procedure (SDS-PAGE) as a protein characterization step.  
The determination of the isoelectric point is another important biochemical characterization 
of phospholipases A2. Previous studies involving phospholipases from snake venoms have 
shown that the acid phospholipases are catalytically more active than their basic isoforms 
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[22, 42, 58]. Therefore, many authors have included, as a biochemical characterization 
parameter, the determination of the isoelectric point of the by isoelectric focusing. Due to pI 
determination importance, Teixeira [25] used the methodology proposed by Vesterberg and 
Eriksson [59] to evaluate pI of BpirPLA2-1. In order to obtain the pI value, a 7% 
polyacrylamide gel was prepared and polymerized over a glass plate of 12 x 14 cm using a 
U shaped rubber as support. A millimeter plate was previously greased with glycerin for 
better refrigeration of the gel. Two strips of Pharmacia Biotech were used to connect the gel 
and the platinum electrodes. The cathode was in contact with NaOH 1 M solution and the 
anode was in phosphoric acid 1 M. The platinum electrodes were centered over the paper 
strips and the system was then closed. The high voltage source was adjusted to the 
maximum values of 500 V, 10 mA, 3 watts and 30 minutes for a pre-run. Following, the 
samples were applied always in the intersection of two blue lines, exactly over the more 
central line of the gel. Then the source was programed for 1500 V, 15 mA, 10 watts and 5 h. 
The end of the run was determined when the source showed a high voltage and low 
amperage (around 1 mA). After isoelectric focusing, about 1 cm width (lengthwise) were 
sliced from each extremity of the gel and placed in test tubes containing 200 µL of distilled 
water for the pH reading after 2 hours of rest. Next, the pH gradient determination graph 
was plotted. The remaining gel containing the samples was fixed in solution of 
trichloroacetic acid for 30 minutes, followed by silver staining. 
Another important technique as a step to characterize components from snake venoms is the 
bidimensional electrophoresis (2D). This one was initially developed by O'Farrell [60]. The 
original methodology consisted of the preparation of polyacrylamide cylindrical gels, in 
which a pH gradient was established through a pre-run with specific amphoterics (also 
called ampholytes), that present high buffering capability in pHs close to their isoelectric 
points (pIs). The proteins were then submitted to an isoelectric focusing (IEF) and 
subsequently to an electrophoresis in the presence of SDS by a conventional system 
described by Laemmli [56]. Then, proteins were separated in the first dimension according 
to their pIs (IEF) and in the second dimension based on their molecular mass (SDS-PAGE).  
Bidimensional electrophoresis is laborious, time consuming and difficult to be reproduced 
in different laboratories and depended on the ability of the researcher to obtain consistent 
results.  Nowadays, many of these problems were solved with the development of new 
technologies. An important advance which has contributed to the increase of the 2D 
electrophoresis reproducibility was developed by Gorg [61] of the strip form gels with 
immobilized pH gradient (IPG - immobilized pH gel). The strips are made by the 
copolymerization of acrylamide with the Immobiline® (Amershan Biosciences/GE Heathcare) 
reagent, which contains acid and alkaline buffering groups. Another important 
technological progress was the improvement of the protein samples preparation methods, 
together with the discovery of new non-ionic detergents, such as CHAPS surfactants and SB 
3-10, used with reducing agents adequate for IEF, like Dithiothreitol (DTT) and Tributyl 
Phosphine (TBP). Studies performed by Herbert [62] demonstrated that these advances had 
strongly contributed to the solubilization of a greater number of proteins to be analyzed in 
bidimensional electrophoresis. 
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The proteomic analysis of snake components has made use of the 2D electrophoresis as a tool, 
due to its high-resolution capability that allows, in a single process, the determination of 
apparent molecular mass and isoelectric point of the venom constituents. Fernandez et al. [22] 
described the determination of the isoelectric point and apparent molecular mass of Basp-
PLA2-II using this technique. In order to do it, the protein was focused in IPG Immobiline® 
Dry Strip of 7 cm and pH 3-10, under a 200 V tension for 1 min, followed by a second stage of 
3500 V for 120 minutes. The second dimension was done in SDS-PAGE 12% and then 
subsequently dyed with Coomassie blue. It was demonstrated that Basp-PLA2 –II had a pI of 
4.9, which is close to the theoretical isoelectric point value (pI 5.05) defined by the primary 
sequence, evaluated using the Compute pI/MW tool (www.expasy.ch/tools) software and 
apparent molecular weight between 15 and 16 kDa, consistent with the molecular weight (MW 
14,212±6 Da) obtained by ESI/MS (Electrospray Ionization/Mass Spectrometry). 
The advantage of this technique is the high resolution. Alape-Giron [63] working with B. 
asper venom, performed an ontogenic analysis and an analysis based on the snake’s capture 
location in different regions of Costa Rica. Using tryptic digestion, MALDI-TOF mass 
fingerprinting analysis and aminoacid sequencing by MALDI-TOF submitted to similarity 
search by BLAST, the author showed the intra-specific variability in venom composition. It 
was hence evidenced that among the venoms obtained from adult species collected in the 
Caribe area and the Pacific area, there are around 30 proteins that are found in a snake 
group from a place which find no correspondents in the other.  
In our lab, this technique has been used as follows: The proteins are separated by the 
isoelectric point in 13 cm strips with pH values varying between 3 and 10 in a nonlinear 
form. These strips contain polyacrylamide gel, where the gradient pH is formed by the 
presence of ampholytes. To re-hydrate the strips, 250 µL of sample [400 µg of proteins plus 
re-hydration solution (7 M of urea, 2 M of Thiourea, 2% of Triton X-100 (v/v/), 1% of IPG 
Buffer® (v/v) and DTT)] is applied in a channel of the apparatus over which the strips are 
set. The strip’s gel is re-hydrated at room temperature for about 12 hours. After this period, 
the strips are taken to the focusing system in the following conditions: (1) 500 V step until 
accumulates 500 Vh; (2) 500 to 1000 V gradient until it accumulates 800 Vh; (3) 1000 to 8000 
V gradient until it accumulates 11300 Vh and (4) 8000 V step until it accumulates 3000 Vh. In 
average, the program run during 5.5 hours, but the time of the final step can be lengthened, 
if the sample does not reach to the end of the strip during the running according the initial 
program, it could be confirmed by a bromophenol blue line. At the end of focusing, the 
strips are equilibrated in two steps. On the first, 10 mL of the solution containing 6 M of 
urea, 2% of SDS (m/v), 30% of glycerol (v/v), 75 mM of Tris-HCl (pH 8,8), 0,002% of 
bromophenol blue and 1% DTT (m/v) for each strip is used. In the second, the same solution 
is used, but DTT is replaced by 2.5% of iodoacetamide (m/v). Each strip equilibrium step run 
during 15 minutes, under light stirring. Following that, the strips are applied on 10 % 
polyacrylamide gels previously prepared on 180 X 160 X 1.0 mm plates. After each strip and 
the standard stay appropriately accommodated in the polyacrylamide gel, a 0,5% agarose 
(m/v) heated (40 °C) solution is added. The agarose polymerization, provides an effective 
contact between the strip and the gel, thus avoiding the appearance of air bubbles. Protein 
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Figure 6. Electrophoretic profile in 2D-PAGE 10%, 13 cm strip pH 3-10 non-linear of proteins from 
crude venom from Bothrops moojeni. Molecular weight (MW) –Color Plus Prestained Protein Marker – 
Broad Range (7-175 kDa) (P7709S). Coomassie G-250. 
separation, according to molecular mass, is done by applying 25 mA per gel and 100 W 
during approximately 5.5 hours. After this period, the gel is washed with deionized water. 
Then, the proteins are fixed using a solution containing acetic acid 10% (v/v) and ethanol 
40% (v/v) during one hour. Then, the fixing solution is removed and the gel is washed again 
with deionized water 3 times during 10 minutes. The proteins present in the gel are exposed 
using traditional methods for protein coloring, such as Coomassie blue or Silver nitrate. An 
example of the practical application of this methodology can be seen in Figure 6. 
4. Functional characterization 
Many biological activities are related to myotoxins with PLA2 structure obtained from snake 
venoms.  In bothropic snake bite accidents and in experimental models with the use of these 
venoms, the noxious activity induced by these toxins on the striated muscles is striking [64]. 
The detection of the myotoxic activity associated to the phospholipase activity detection (in 
the case of Snake venom PLA2 Asp49) is used as an important auxiliary biological marker in 
the purification procedures, monitoring its presence. 
The myotoxic activity assay can be done in two ways: in vivo and in vitro. The analysis can 
be done through the quantification of the released intracellular enzymes activity to the 
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periphery blood or to the supernatant of the culture medium of cellular lineages. There are 
two main enzymes used to this end: 
Creatine Kinase (EC 2.7.3.2): is a dimeric protein formed by the combination of subunits (B 
and M) and in its cytosolic form is found in many tissues, especially in skeletal muscle tissue 
(CK-MM), cardiac (CK-MB) and in the brain (CK-BB). 
Lactate dehydrogenase (EC 1.1.1.27): is an enzyme widely distributed in many tissues and 
organisms. It is presented in the form of homo or hetero tetramers of subunits M and H, 
being present in muscular tissue in the homotetrameric form of subunit M. 
In vivo, the CK activity quantification in murine models has been the most used to assay the 
presence of myotoxic PLA2, especially due to their low cost, ease of performance and high 
specificity as skeletal muscular tissue lesion markers when exposed to myotoxins. 
As for the In vitro assays, myoblast lineages C2C12 (ATCC CRL-1772), differentiated until the 
formation of myotubules, have been used as models to assay the cellular toxicity, through the 
quantification of LDH levels in the supernatant of cell cultures exposed to toxins.  
Regarding the phospholipase activity detections, it can be done by direct and indirect 
methods. Directly, it is possible to detect the presence of PLA2s with the use of chromogenic 
substrates, such as 4N3OBA(4-nitro-3-octanoyloxybenzoic acid) that induce the formation of 
detectable product at 425 nm [65] and fluorescent substrates (NBD) coupled to 
phospholipids that are used to quantitively and qualitatively survey the PLA2s activity 
isolated from snake venom [23]. 
Indirectly, the approach used consists in the potentiometric assay of the fatty acids released 
after the enzymatic hydrolysis of the phospholipids, through the quantification with standard 
alkaline solution [66]. Moreover, fatty acids released by the enzymatic degradation can be 
quantified through the alteration of the optical density of the pH indicator solution, such as 
phenol red [67], brilliant yellow [68] and bromothymol blue [69]. Another indirect method to 
assay PLA2 activity present in samples consists in the detection of hemolysis induced by 
lysophospholipids derived from phospholipids submitted to enzymatic digestion. This can be 
done through the quantification of hemoglobin present in solution or through the visualization 
of hemolytic halo in agarose matrix with immobilized red blood cells.  
4.1. In vivo assay of the myotoxic activity 
Mice is used for the in vivo assay of the myotoxic activity. Swiss males weighing between 18 
g and 22 g, kept in controlled environment (12 h in the light and 12 h in the dark), with food 
and water ad libitum up to the moment of use. PBS solubilized sample and control (PBS) are 
filtered through 44 µm pores immediately prior to use. Reagents for CK activity dosage are 
prepared and used according to manufacturer’s instructions. 
A Sample (50 µL) or control (50 µL) will be injected in mice gastrocnemic muscle using 
adequate device in order to guarantee a precise volume control. After a time lap (3 and/or 6 
h), blood sample is collected in heparinized tubes and centrifuged to separate plasma. CK 
 
Purification of Phospholipases A2 from American Snake Venoms 21 
concentration is determined according to manufacturer’s instructions and expressed in U/L, 
where one unit corresponds to the production of 1 mmol of NADH per minute [26,70-72]. 
4.2. In vitro myotoxic activity assay 
In order to assay myotoxic in vitro activity, myoblast lineage cells are used, such as murine 
skeletal muscle C2C12 myoblasts (ATCC CRL-1772) as described by Lomonte et al. [73], 
cultivated in modified Dubelco Eagle medium, supplemented with 1% bovine fetal serum. 
PBS solubilized sample, negative control (PBS) and positive control (Triton X-100) should be 
filtered through 22 µm pore filters immediately prior to use. Reagents for LDH activity 
dosage are prepared and used according to manufacturer’s instructions. 
In 96 well plate, 2X105 cells/150 µL are set, sample and/or control (50 µL) are incubated in 
humid atmosphere at 37 °C and 5% CO2 for a 3 hour period. Afterwards, collect supernatant 
aliquot and quantify LDH activity released by cells with cytoplasmic membrane integrity 
compromised, according to manufacturer’s instructions and expressed in U/I, where one 
unit corresponds to the production of 1 mmol of lactate per minute. 
5. Phospholipasic activity 
5.1. 4N3OBA Substrate enzymatic hydrolysis 
Phospholipase A2 activity can be measured according to the technique described by Holzer 
and Mackessy [65], modified for 96 wells plate [74]. 
Prepare aliquots of 100 µL of 4N3OBA 0.1% solution in acetonitrile and lyophilize. Keep the 
aliquots at -20° C until ready to use. The color reagent is prepared solubilizing the contents of 
one aliquot of 4N3OBA in 1ml of reagent containing Tris 10 mM, CaCl2 10 mM, NaCl 100 mM, 
and pH 8.0. For the test in micro plates, add 180 µL of color reagent and 20 µL of sample or 
water (blank), incubate the mixture at 37 °C for 5 minutes, measuring the optical density at 425 
nm and 600 nm (to correct sample turbidity) at 30 second intervals. The activity will be 
expressed according to the equation (1) where 1 unit of phospholipase activity corresponds to 
the production of 1 µmol of 4-nitro-3-hydroxy-benzoic acid per minute. 
 ( )
2PLA  activity mol   min 1 g 1   
OD425nm OD 600nm / min  x 0.07862 umol / OD425nm  /  1 / protein 1 / g
µ µ
µ
 − − = 
   −   
 (1) 
5.2. Enzymatic hydrolysis of fluorescent substrates (NBD) 
The phospholipase activity can also be assayed with the used of chromogenic substrates, 
using acyl-NBD reagents: NBD-PC (Phosphatidylcholine), NBDPG (phosphatidylglycerol), 
NBD-PE (phosphatidylethanolamine) or NBD-PA (phosphatidic acid). A solution of 
fluorescent lipids should be previously prepared in a 1 mg/ml concentration in chloroform. 
100 µL aliquots are distributed and then dried under nitrogen flow. The dried lipid will be 
solubilized in 1 ml of NaCl 0.15 M and sonicated until the obtention of a limpid solution. For 
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the test, the lipids should be diluted in a solution containing Tris-HCl 50 mM, CaCl2 1 mM 
pH 7.5. Initially, incubate the solution at 37 °C and, after 2 minutes, make an initial reading, 
configuring the equipment for excitation at 460 nm and emission at 534 nm. Following, 
apply the sample and make a second reading after 12 minutes. The change in fluorescence 
intensity is converted to nanomoles of product per minute (nmoles/min) using a calibration 
curve, prepared by hydrolyzing completely a substrate solution through sodium hydroxide 
treatment. The fluorescence intensity unit was converted to nmoles/min [33]. 
5.3. Potentiometric titration of fatty acids 
The phospholipase activity can be assayed by potentiometric titration as described by de 
Haas [75], using as substrate an egg yolk emulsion in the presence of sodium deoxycholate 
0.03 M and CaCl2 0.6 M. Fatty acids released enzymatically are titrated with a standard 
solution of NaOH 0.1 N at pH 8.0 at room temperature. The phospholipase activity is 
generally done with different concentrations of toxin, and calculated per amount of 
microequivalents of alkali consumed per minute, by mg of protein. One unit of 
phospholipase activity can be defined as the quantity of enzyme that releases 1 µmol of fatty 
acid per minute, in the reaction conditions. 
5.4. Phenol red 
The spectrophotometric detections of phenol red solution, induced by the increase of free 
fatty acids concentration can also be used to assay the phospholipase activity in samples, as 
described by Radvanyi [67]. 
In order to use this technique, prepare the reagent solution containing Phosphatidylcholine 
0.25% (w/v) TritonX-100 0.4% (v/v), phenol chloride 32 mM. In a thermostatic cuvette at 
37 °C, add 1mL of reagent solution and 10 µL of sample. After stabilization for 20 seconds, 
determine the optical density measuring at 558 nm for 3 minutes, in kinetic intervals of 15 
seconds. One unit of phospholipase can be defined as the quantity of enzyme necessary to 
convert 0.001 UA 558 nm per minute. 
5.5. Indirect hemolysis 
In this test, phospholipids (from egg yolk, soy lecithin or other sources) are used as 
substrates, with the production of fatty acid and corresponding lysophospholipids. 
These lysophospholipids have membrane activity over red blood cells, producing hemolysis 
that can be detected through the quantification of hemoglobin present in solution or through 
a hemolysis halo present in agarose gel containing intact red blood cells [76]. 
For the test, collect blood in a heparinized tube, wash the red blood cells with PBS, 
centrifuging at 800 xg for 5 minutes and prepare the suspension at 3%. Prepare solution 
containing phosphate buffer 20 mM, sodium chloride 100 mM and CaCl2 10 mM, 
erythrocyte suspension 3% (1:30 v/v) and egg yolk solution 0.1% (1:30 v/v). Add 10 µL of 
sample or PBS (control 0%) or Triton X-100 0.1% (control 100%) and incubate at 37 °C for 30 
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minutes. Then, centrifuge, collect the supernatant and determine the optical density at 405 
nm, using PBS as blank. The results will be expressed in % of hemolysis compared with the 
positive control. 
Hemoglobin dosage present in solution with the use of the Drabkin reagent (potassium 
ferrocyanide in buffered environment) [77] can be done by comparing the optical density of 
the samples with the standard curve made with the hemoglobin cyanide solution, according 
to manufacturer instructions. 
To assay the hemolytic activity in agarose gel, carefully heat the suspension containing 
agarose 2% in PBS until complete fusion. After partial cooling (45 °C), add an equal volume 
of PBS containing CaCl2 0.02 M; egg yolk suspension (1:30 m/v), erythrocytes washed in PBS 
(1:30 m/v), pouring over Petri plate until the formation of a layer approximately 2 mm thick. 
After solidification of the gel, orifices of uniform diameter (0.2 cm diameter) to apply the 
sample are made. The gel is incubated for 12 hours, at 37 °C and humid environment. The 
formation of a translucid halo around the gel application point is indicative of 
phospholipase activity, contrasting with the rest of the gel which remains with a reddish 
tone due to the presence of integral red blood cells retained in the gel net. 
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